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Abstract
Objective—To examine whether longitudinal changes in relative weight category (as indicated
by change in BMI classification group) were associated with changes in nuclear magnetic
resonance (NMR) derived lipoprotein particles among US youth.
Study design—Secondary analysis of data from clustered RCT. BMI and fasting blood samples
were obtained from 2069 participants at the start of 6th grade and end of 8th grade. BMI was
categorized as normal weight, overweight or obese at both time points. Lipoprotein particle
profiles were measured using NMR spectroscopy at both time points. Regression models were
used to examine changes in relative weight group and change in lipoprotein variables.
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Results—38% of participants changed relative weight category (BMI group) over the 2.5 year
study period. Low density lipoprotein cholesterol and non-high density lipoprotein cholesterol
decreased almost universally, but more with improved BMI category. There were adverse effects
on LDL size and total LDL particles, high density lipoprotein size and cholesterol for participants
who remained obese or whose relative weight group worsened. Changes in relative category had
no impact on HDL particles.
Conclusion—Improvement in relative weight group from 6th to 8th grade was associated with
favorable changes in non-HDL-C, VLDL size, LDL size, HDL size and LDL particles, but had no
effect on HDL particles. Findings indicate that an improvement in relative weight group between
6th and 8th grade had an effect on NMR derived particles sizes and concentrations among a large
group of adolescents, which overrepresented low-income minorities.
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There is substantial evidence that insulin resistance in adults and children (1) is associated
with high triglyceride levels and low levels of high density lipoproteins. Recent adult studies
using nuclear magnetic resonance (NMR) spectroscopy have suggested that low density
lipoprotein particle (LDL-P) concentration and size may have stronger associations with
insulin resistance and the metabolic syndrome than traditional lipoprotein lipid measures (2).
LDL-P and LDL particle size may provide early markers for cardio-metabolic risk and both
incident type 2 diabetes (T2DM) and cardiovascular disease (CVD)(3, 4).
Emerging evidence indicates that NMR lipoprotein profiles are associated with obesity and
insulin resistance in children. For example, Magge et al reported there was no difference in
levels of low-density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol
(HDL-C) and triglycerides (TG) comparing obese, children with pre-diabetes with obese but
children with normo-glycemia (5). However, participants with pre-diabetes had higher
concentrations of small LDL-P and a smaller average LDL particle size. Moreover, a
number of studies have shown that obese children have higher levels of small and total
LDL-P than non-obese children(6, 7).
In adults, a diet and exercise regime that reduces total and visceral fat and improves insulin
sensitivity has been shown to yield favorable changes in NMR-derived lipoprotein particles
(8). Longitudinal data have shown that non-obese adults who were overweight in childhood
have levels of elevated lipids comparable with individuals who had a healthy weight at both
time points (9). Thus, we examined the associations between 2.5-year changes in relative
weight category and changes in NMR-derived lipoprotein particles in 2069, 6th graders, 75%
of whom were Black or Latino, and 50% of whom were overweight or obese.
METHODS
This report is an analysis of stored blood from the HEALTHY Study, a US National
Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) cluster randomized
controlled trial that aimed to reduce the prevalence of risk factors for type 2 diabetes
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mellitus among middle school children (6th – 8th grade). The main study design has been
detailed elsewhere (10, 11, 12). Briefly, participants were recruited from 42 middle schools
across the US. Schools had at least 50% of students eligible for free or reduced-price lunch
or belonging to an ethnic minority group and an annual student attrition rate ≤ 25%. The
intervention included changes to the physical education curriculum school food service,
health education, and a school wide social marketing campaign (11, 13–17). The sample for
this study is limited to participants who provided parental consent and child assent for
ancillary analyses of stored blood, and for whom complete data were available. The study
was approved by the Institutional Review Boards at each field center, and written informed
parental consent and child assent were obtained.
Height and body mass were measured without shoes using the Prospective Enterprises PE-
AIM-101 stadiometer and the SECA Corporation Alpha 882 electronic scale. Body Mass
Index (kg/m2) was calculated and converted to an age- and sex-specific BMI percentile
using CDC 2000 criteria (18). Students with BMI ≥5th percentile and <85th percentile were
classified as healthy weight. The healthy weight range was then subdivided into 2 groups:
BMI ≥5th percentile and <50th percentile and BMI ≥50th percentile and <85th percentile.
Youth with BMI ≥85th percentile but <95th percentile were classified as overweight, those
with BMI between 100% and 119% of the >95th percentile classified as obese and those at
or above 120% of the 95th percentile classified as severely obese (19) and those with BMI
<5th percentile were classified as underweight. Waist circumference was taken using a
Gulick tape measure (G-tape) with a tension device on bare skin measured just above the
iliac crest.
At baseline (beginning of 6th grade) and follow-up (end of 8th grade) fasting blood samples
were collected from all participants. Standard lipid profiles including total cholesterol (TC),
TG, and HDL-C were measured by CDC-standardized direct assay at the University of
Washington (20). LDL-C was calculated using the Friedewald equation (21). Analyses of
glucose were performed using reagent from Roche Diagnostics. Insulin was measured by a
two-site immuno-enzymometric assay. Fasting insulin (performed using a Tosoh 1800 auto-
analyzer) and glucose (performed on a Roche P module auto-analyzer by the hexokinase
method) were used to calculate the homeostatic model assessment of insulin resistance
(HOMA-IR) according to the formula: Glucose*Insulin / [μU/L] 22.5 (22).
Lipoprotein particle profiles were measured by NMR spectroscopy with the LipoProfile-3
algorithm at LipoScience, Inc (Raleigh, NC) on frozen EDTA plasma specimens of
participants who provided informed consent for ancillary studies. VLDL, LDL and HDL
subclasses were quantified from the amplitudes of their spectroscopically-distinct lipid
methyl group NMR signals, and weighted-average particle sizes were derived from the sum
of the diameter of each subclass multiplied by its relative mass percentage based on the
amplitude of its methyl NMR signal.21 Diameter range estimates for the subclasses were as
follows: large VLDL-P, >60 nm; medium VLDL-P, 35–60 nm; small VLDL-P, 29–35 nm;
intermediate-density lipoprotein particles (IDL-P), 23–29 nm; large LDL-P, 20.5–23 nm;
small LDL-P, 18 to 20.5 nm and very small LDL-P <20.5 nm); large HDL-P, 9.4–14 nm;
medium HDL-P, 8.2 to 9.4 nm; small HDL-P, 7.3–8.2 nm. VLDL-P, LDL-P and HDL-P are
the totals of the particle numbers of the respective VLDL, LDL and HDL subclasses. Also
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reported is a multivariate lipoprotein insulin resistance score (LP-IR) which is derived by
combining the 6 lipoprotein subclass and size measures most strongly associated with
insulin resistance (large VLDL-P, small LDL-P, large HDL-P, and VLDL, LDL, and HDL
size) (23). LP-IR values range from 0 (most insulin sensitive) to 100 (most insulin resistant).
Inter-assay reproducibility (coefficient of variation), determined from 80 replicate analyses
of 8 plasma pools over 20 days, was 6% for LP-IR, 8, 3, and 2% for total VLDL-P, LDL-P,
and HDL-P; 0.7% for LDL and HDL size; 4% for VLDL size; 7, 13, and 22% for large,
medium, and small VLDL-P; 43, 12, and 10% for IDL-P, large, and small LDL-P; and 9, 14,
and 6% for large, medium, and small HDL-P, respectively.
Pubertal status was self-reported using the Pubertal Development Scale (24) and converted
to pubertal stage groups consistent with the five pubertal stages outlined by Tanner (25).
Ethnicity and household education were obtained via parental report and sex was self-
reported.
Statistical analyses
We created 7 categories to examine shifts in relative weight categories from grades 6
through 8 (categories with small numbers were collapsed): (1) overweight to obese or
severely obese; (2) healthy weight to overweight, obese, or severely obese; (3) stayed obese
or severely obese; (4) stayed overweight; (5) stayed healthy weight; (6) overweight to
healthy weight; and (7) obese or severely obese to overweight or healthy weight. Categories
were collapsed further for modeling because of small cell sizes; specifically the first 2 BMI
categories collapsed into a “worsened” category and the last 2 categories into an “improved”
category. Finally, underweight students (N=43, 2%) were excluded from modeling as
shifting to the healthy weight range was not expected to be associated with increased risk.
Descriptive statistics, including means, standard deviations, and percentages were calculated
for all variables. The effect of the intervention upon NMR variables was examined using
general linear mixed models which took into account sources of variability within and
between schools and controlling for baseline values of the NMR variables. As these analyses
indicated no consistent effect of the intervention on NMR variables, we evaluated whether
longitudinal shifts in relative weight group differed by sex, race/ethnicity, sixth-grade
pubertal stage, and highest household education level by using separate general linear mixed
models that adjusted for school intervention status and took into account sources of
variability within and between schools and controlled for baseline BMI percentiles. Separate
mixed models were also used to analyze associations between shifts in relative weight group
and changes in lipoprotein measures. Baseline lipoprotein values of interest, school
intervention status, sex, race/ethnicity, sixth-grade pubertal stage and highest household
education level were included as covariates. All models tested for shifts in relative weight
category as main effects. Covariates were also tested as main effects as well as the
interaction between the covariates and BMI category shift when the covariates were
significant. There was no pattern of significance with the covariates across all models, but
based on the results in previous work, subgroup analysis was performed by sex where the
interaction between sex and BMI category shift was statistically significant: small LDL-P,
HDL size and LP-IR (10). To evaluate the impact of specific shifts in relative weight
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category, we conducted pair-wise comparisons between each of the shift categories. P-
values <0.05, with Bonferroni corrected p-values applied to multiple comparisons, were
considered significant. SAS 9.2 statistical software (SAS Institute, Cary, NC) was used for
analyses.
RESULTS
Participant demographic information is presented for all 2069 participants and by sex in
Table I (available at www.jpeds.com). Boys were more likely to be overweight and obese
than girls. Demographic information and baseline lipoprotein profiles of the participants
included and excluded from the analyses due to incomplete data or being classed as
“underweight” are presented in the Figure (available at www.jpeds.com). There was a higher
BMI percentile (73.6 vs. 67.6, p = 0.0047) and lower HDL-C (52.5 vs. 55.0 mg/dL, p =
0.0296) in those included, vs. those excluded, from NMR analysis.
Table II presents information regarding changes in relative weight categories during the
period from 6th to 8th grade. The majority of children (62%) did not change their BMI
category. Consistent with the overall results of the trial (12), more children showed an
improvement versus a worsening in their relative weight category (479 vs. 306, p<0.0001).
The median levels (with inter-quartile ranges) or mean (plus 95% confidence intervals) of
each of the variables are presented for all 6th grade, 8th grade variables as well as the
difference (8th grade – 6th grade) are shown in Table III. There was a mean increase in
insulin levels and HOMA-IR but a mean decrease in the number of LDL particles across all
participants.
The medians and inter-quartile ranges and change from 6th to 8th grade for LDL and HDL
measures related to change in relative weight category are presented in Table IV, which also
includes a summary of evidence documenting significant changes of these variables among
participants as a function of shift in relative weight category. The information in the last
column therefore indicates the comparisons that showed a significant relationship between
weight category change and variable of interest after adjustment for multiple testing.
Although LDL-C fell in all categories, the greatest decline was present in those whose
relative weight group improved. It is noteworthy that LDL-C was around 10–15% higher in
the participants who stayed obese than the participants who remained in the healthy weight
group, and the magnitude of the between group disparity in LDL-P was much higher
(around 50%). This difference could be explained by the smaller LDL particle size in the
group that remained obese. Total LDL-P increased in the BMI worsened group but
decreased in the BMI improved group suggesting a benefit of improving BMI group on
CVD risk.
The medians and inter-quartile ranges and change from 6th to 8th grade of HOMA-IR and
the lipid and lipoprotein particle measures most strongly associated with insulin resistance
are presented in Table V. When the BMI category improved, VLDL size decreased, LDL-
size increased and small LDL-P decreased. Conversely, when the BMI category worsened,
VLDL size increased and there was a downstream decrease in LDL size and an increase in
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small and total LDL-P. The observed changes in HDL particle size paralleled changes in
LDL size; there was an increase in large HDL with a decrease in BMI category and a
reduction in large HDL when BMI category increased. There was no evidence of pair-wise
differences in HDL-P, however. Also noteworthy among these data were the differences in
the HOMA-IR and TG/HDLC levels of the group that remained obese when compared with
those remaining at a healthy weight. Similar trends were evident for LP-IR (a composite
lipoprotein / insulin score), indicating a difference in potential risk of insulin resistance.
The Figure shows the change in the three variables for which there was a sex interaction
(small LDL-P, HDL size and LP-IR), and indicates that for small LDL-P the mean adjusted
change was greater in boys than girls in all worsening groups with a particularly marked
difference among the BMI increased group. There was a comparable pattern for both HDL
size and LP-IR indicating that for these three variables increase in BMI group appears to
have a more marked effect on boys than girls.
DISCUSSION
The present findings expand the current understanding of obesity-related risk factors in
youth, by providing new information about the impact of change in relative weight category
on NMR variables. In this study, the overall number of HDL particles (HDL-P) did not
appear to be related to change in relative weight category, but change in category was
associated with change in HDL particle size. This finding is consistent with several recent
studies which have reported that lifestyle interventions have yielded changes in particle
subclass distribution but not the number of particles (26, 30). The full functional
significance of HDL subspecies is not known, but an abundance of the larger species may
reflect improved insulin sensitivity (31). A relatively greater depletion of large HDL
subspecies compared with the smaller forms has been observed in patients with metabolic
syndrome (32) and type-2 diabetes (33), suggesting that decreased HDL-P may also be a
sensitive risk biomarker for these inflammatory conditions (34). Collectively, these findings
suggest that HDL-P is difficult to change with drugs or modest lifestyle intervention, but
increased particle size may reflect improved cardiometabolic status.
The analyses reported here demonstrate that with a worsening of relative weight group there
are increased numbers of small cholesterol-poor LDL subspecies. Small LDL-P are cleared
30–50% less efficiently than larger particles, and therefore linger in the vascular space,
raising the total LDL-P concentration. Higher levels of LDL-P increase the susceptibility to
vascular wall interactions which can lead to atherogenesis.(39) Meanwhile, more
triglyceride-rich HDL are also generated and metabolized to smaller, more rapidly-cleared
HDL subspecies.(34) It has been reported that premature coronary endothelial dysfunction
and atherosclerosis in a cohort of adults referred for evaluation of chest pain correlate with
LDL-P and inversely with HDL-P, independent of traditional cholesterol measures.(40)
Collectively, these findings demonstrate that NMR-derived lipoprotein measures are
markers of cardiometabolic risk that track with BMI changes in children, with implications
for CVD risk reduction.
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The present data show changes in NMR lipid measures from 6th to 8th grade were associated
with increased cardiovascular risk for subjects who became or remained obese. These
longitudinal changes reflected a more atherogenic lipoprotein profile (with increased VLDL
size and decreased LDL and HDL size due to a shift toward smaller LDL and HDL
particles), with nascent or persistent obesity. In contrast, over the 2.5 year study interval,
traditional lipid measures (LDL-C, TG and non-HDL-C) improved overall. These data are
consistent with previously described lipid changes associated with puberty. (48)
Nonetheless, even with traditional lipid measures, obesity was associated with the
attenuation of these improvements. These observations suggest that the assessment of
cardiovascular risk using NMR may be less prone to the confounding effects of puberty,
and, therefore, more clearly reflective of CVD risk.
The major strength of this report is the ethnically diverse sample of US adolescents. It is also
important to highlight that the current analyses were conducted on 87.4% of the overall
participants with stored blood. Although this is a significant sub-group of the overall sample,
the interpretation of our results requires caution, as there were some significant differences
between the participants included versus those excluded from our analyses. Moreover,
although self-reported physical activity and dietary data were collected from participants,
the high levels of missing data on these variables prevented us from controlling for change
in these variables.
It is also important to recognize that our period of assessment occurred when participants
were progressing through puberty which exerts profound effects on key outcome variables.
We employed a self-reported measure of puberty which, although shown to be valid in this
group, is less accurate than physical examination; combined with the high levels of missing
data at the 8th grade meant that we cannot adjust for change in pubertal status. Although the
models were adjusted for self-reported pubertal status it is possible that some residual
confounding by pubertal stage might have remained. Finally, it is important to acknowledge
that change in BMI category was used in the analyses and not change in absolute BMI.
Among participants whose BMI improved, some participants would have improved more
than others and this potential difference is not accounted for in the analysis.
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Changes (95% CI) in small LDL-P, HDL size, and LP-IR in boys and girls as a function of
BMI Category Shifts from 6th Grade to 8th Grade *
* Girls are denoted by circles in figures and boys by squares.
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Table 1
Baseline Participant Characteristics (N=2069) and p-values testing for sex differences
OVERALL Female (N=1115) Male (N=954)
p-valueMean (SD) or N and % Mean (SD) or N and % Mean (SD) or N and %
Age (years) 11.29 (0.57) 11.24 (0.54) 11.35 (0.60) <.0001
BMI Percentile 73.65 (27.59) 72.21 (27.42) 75.32 (27.72) 0.0105
BMI Category 0.0005
 < 85th Percentile 1018 49.2% 588 52.7% 430 45.1%
 85th – 94th Percentile 402 19.4% 222 19.9% 180 18.9%
 ≥ 95th Percentile 649 31.4% 305 27.4% 344 36.1%
Race/Ethnicity 0.0499
 Hispanic 1268 61.3% 688 61.7% 580 60.8%
 Black 386 18.7% 218 19.6% 168 17.6%
 White 415 20.1% 209 18.7% 206 21.6%
Positive Reported 1st Degree Family History of
Diabetes
265 12.8% 141 12.6% 124 13.0% 0.8168
Highest Household Education 0.0989
  No HS Diploma 556 26.9% 315 28.3% 241 25.3%
  Some college 1100 53.2% 593 53.2% 507 53.1%
  College grad or higher 413 20.0% 207 18.6% 206 21.6%
Pubertal Status <.0001
  Tanner Stage 1 202 9.8% 59 5.3% 143 15.0%
  Tanner Stage 2 535 25.9% 148 13.3% 387 40.6%
  Tanner Stage 3 849 41.0% 479 43.0% 370 38.8%
  Tanner Stage 4 436 21.1% 384 34.4% 52 5.5%
  Tanner Stage 5 47 2.3% 45 4.0% 2 0.2%
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Table 3
6th Grade, 8th Grade and Change (8th-6th) in BMI, Waist Circumference, HOMA-IR and NMR Variables
with Underweight Dropped
6th Grade 8th Grade Difference (8th-6th)
BMI Percentile 75.06 (73.92, 76.19) 74.45 (73.38, 75.52) −0.60 (−1.17, −0.04)
Waist Circumference (cm) 76.36 (75.73, 76.99) 81.01 (80.38, 81.64) 4.60 (4.31, 4.89)
Glucose 93.70 (93.42, 93.99) 94.23 (93.86, 94.61) 0.53 (0.16, 0.90)
Insulin 13.62 (13.12, 14.11) 17.45 (16.78, 18.12) 3.83 (3.23, 4.43)
HOMA-IR 3.19 (3.07, 3.31) 4.12 (3.95, 4.28) 0.93 (0.78, 1.08)
Total Cholesterol 155 (139, 174) 146 (130, 164) −9 (−22, 4)
LDL-C (mg/dL) 86 (71, 101) 78 (65, 93) −7 (−17, 3)
LDL–P (nmol/L) 682 (516, 894) 636 (495, 832) −39 (−179, 90)
 IDL–P (nmol/L) 113 (72, 164) 88 (55, 126) −23 (−74, 21)
 Large LDL–P (nmol/L) 312 (186, 434) 319 (200, 435) 13 (−106, 133)
 Small LDL–P (nmol/L) 189 (27, 495) 147 (27, 438) −6 (−174, 67)
LDL Particle Size (nm) 21.5 (20.7, 22.2) 21.6 (20.9, 22.2) 0.1 (−0.6, 0.7)
Non-HDL-C (mg/dL) 103 (87, 121) 94 (79, 110) −8 (−20, 2)
HDL-C (mg/dL) 51 (44, 59) 50 (43, 59) 0 (−6, 5)
HDL–P (umol/L) 33.0 (30.4, 35.8) 31.7 (29.1, 34.2) −1.5 (−4.1, 1.5)
 Large HDL–P (umol/L) 6.0 (3.9, 8.5) 6.2 (4.1, 8.8) 0.2 (−1.1, 1.5)
 Medium HDL–P (umol/L) 10.2 (7.6, 13.1) 9.1 (6.6, 11.9) −1.0 (−3.9, 1.6)
 Small HDL–P (umol/L) 16.3 (13.7, 19.1) 15.9 (13.2, 18.5) −0.6 (−3.2, 1.9)
HDL Particle Size (nm) 9.5 (9.2, 9.9) 9.6 (9.2, 9.9) 0.0 (−0.2, 0.3)
Triglycerides (mg/dL) 78 (56, 108) 72 (53, 99) −6 (−26, 13)
Triglycerides:HDL-C 1.5 (1.0, 2.3) 1.4 (1.0, 2.1) −0.1 (−0.6, 0.3)
VLDL-P (umol/L) 38.1 (25.4, 54.9) 34.3 (23.8, 50.8) −3.0 (−15.3, 9.3)
 Large VLDL-P (umol/L) 2.0 (1.2, 4.0) 1.7 (1.1, 2.8) −0.3 (−1.6, 0.5)
 Medium VLDL-P (umol/L) 14.4 (8.1, 24.2) 13.2 (7.2, 22.7) −1.1 (−8.0, 5.8)
 Small VLDL-P (umol/L) 19.3 (12.1, 27.7) 18.0 (12.0, 26.2) −1.0 (−9.3, 7.2)
VLDL Particle Size (nm) 49.7 (46.7, 53.3) 49.1 (46.3, 52.6) −0.6 (−4.4, 3.0)
LP-IR 35 (21, 53) 31 (18, 48) −3 (−14, 7)
HOMA-IR, Total Cholesterol, LDL-C, LDL-P, IDL-P, Large LDL-P, Small LDL-P, LDL Particle Size, HDL-C, HDL-P, Large HDL-P, Medium
HDL-P, Small HDL-P, HDL Particle Size, Triglycerides, Triglyceride:HDL-C, VLDL-P, Large VLDL-P, Medium VLDL-P Small VLDL-P,
VLDL Particle Size, and LP-IR are presented as medians and (25th percentile, 75th percentile) while BMI percentile, waist circumference,
glucose, and insulinare presented as mean and 95% confidence interval.
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